ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in ESSA Pharma Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q2 2023
- Shares held
- 33.5M
- +219.7K (+0.7%) vs. Q2 2023
- Total value
- $103.4M
- +$13.6M (+15.2%) vs. Q2 2023
- New holders
- 1
- 10 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 8 | $25 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 31 | $96 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 48 | $148 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $155 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 165 | $510 | 0.00% | −265−61.6% | Reduced |
| Laurel Wealth Advisors LLC | 600 | $1.85K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $2.64K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,288 | $3.98K | 0.00% | +1,288 | New |
| Royal Bank of Canada | 1,498 | $4.00K | 0.00% | +723+93.3% | Added |
| Simplex Trading, LLC | 3,669 | $11.0K | 0.00% | −2,020−35.5% | Reduced |
| Citadel Advisors LLC | 5,475 | $16.9K | 0.00% | −5,408−49.7% | Reduced |
| BlackRock Inc. | 7,677 | $23.7K | 0.00% | +5,416+239.5% | Added |
| Hunting Hill Global Capital, LLC | 10,000 | $30.9K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12,000 | $37.1K | 0.00% | +6,775+129.7% | Added |
| Two Sigma Investments, LP | 15,188 | $46.9K | 0.00% | −6,758−30.8% | Reduced |
| Acadian Asset Management LLC | 15,903 | $48.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,039 | $58.8K | 0.00% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 20,032 | $61.1K | 0.05% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 21,695 | $67.0K | 0.00% | +7,290+50.6% | Added |
| JPMorgan Chase & Co | 29,427 | $90.9K | 0.00% | −14,446−32.9% | Reduced |
| Group One Trading, L.P. | 41,860 | $129.3K | 0.01% | +10,596+33.9% | Added |
| Two Sigma Advisers, LP | 56,900 | $175.8K | 0.00% | −25,400−30.9% | Reduced |
| Connective Capital Management, LLC | 84,578 | $261.3K | 0.60% | −58,149−40.7% | Reduced |
| Susquehanna International Group, LLP | 95,758 | $295.9K | 0.00% | +46,228+93.3% | Added |
| CIBC World Markets Inc. | 149,143 | $461.0K | 0.00% | −11,500−7.2% | Reduced |
| D. E. Shaw & Co., Inc. | 168,050 | $519.3K | 0.00% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 356,500 | $1.10M | 0.12% | 00.0% | Unchanged |
| Millennium Management LLC | 473,556 | $1.46M | 0.00% | +4,554+1.0% | Added |
| Rock Springs Capital Management LP | 677,005 | $2.09M | 0.06% | +13,688+2.1% | Added |
| OrbiMed Advisors LLC | 842,366 | $2.60M | 0.06% | −79,574−8.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $3.22M | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 4,182,683 | $12.9M | 0.00% | +312,603+8.1% | Added |
| PFM Health Sciences, LP | 4,199,253 | $13.0M | 0.62% | −5,700−0.1% | Reduced |
| Soleus Capital Management, L.P. | 4,287,094 | $13.2M | 1.33% | +85,000+2.0% | Added |
| Bellevue Group AG | 7,898,583 | $24.4M | 0.39% | 00.0% | Unchanged |
| BVF Inc | 8,748,629 | $27.0M | 0.73% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −24,414−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −12,489−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −27−100.0% | Sold out |